Search clinical trials for: Ranibizumab

Total 621 results

Peter A Campochiaro, MD
Genentech, Inc.

Completed

Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein Occlusions (RELATE)

Retinal Vein Occlusion

United States
David M. Brown, M.D.
Novartis Pharmaceuticals

Terminated

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration

Age-Related Macular Degeneration

United States
Novartis

Completed

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)

Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
Arshad Khanani
Genentech, Inc.

Completed

Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

Neovascular Age-Related Macular Degeneration

United States
M.D. Anderson Cancer Center
Susan G. Komen Breast Cancer Foundation

Completed

The Impact of Obesity and Obesity Treatments on Breast Cancer

Breast Cancer

United States
Queen's University

Completed

Treatment of Epiretinal Membranes With Ranibizumab (LERM)

Epiretinal Membrane

Canada
Unity Health Toronto

Unknown

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study

Diabetic Macular Edema
Ruijin Hospital
Ningbo University

Completed

Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

Diabetic Retinopathy | Glaucoma, Neovascular
Instituto de Olhos de Goiania

Completed

Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema

Retinal Diseases
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Completed

Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

Retinal Vein Occlusion

United States
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Withdrawn

Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Choroidal Neovascularization

United States
Instituto de Olhos de Goiania

Completed

Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis

Glaucoma | Rubeosis Iridis

Brazil
Valley Retina Institute

Unknown

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion (ORION)

Central Retinal Vein Occlusion | Macular Edema

United States
Alcon Research
Novartis Institutes for BioMedical Research

Withdrawn

A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema

Diabetic Macular Edema
Ohr Pharmaceutical Inc.
Cumberland Valley Retina Consultants, PC

Completed

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Macular Edema | Retinal Vein Occlusion
Bayer
Regeneron Pharmaceuticals

Completed

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy (POLARIS)

Macular Degeneration | Macular Edema | Ophthalmology

Slovakia, France, Germany, Spain, Russian Federation, United Kingdom, Portugal, Greece
José Cunha-Vaz

Completed

Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy

High Risk Proliferative Diabetic Retinopathy

Portugal
Allergan

Terminated

A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration

Age-Related Macular Degeneration | Choroid Neovascularization

United States, Australia, Philippines
Fukushima Medical University

Unknown

Retinal Sensitivity in BRVO After Anti-VEGF Therapy

Branch Retinal Vein Occlusion

Japan
Federal University of São Paulo
Novartis

Withdrawn

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy

Choroidal Neovascularization | Retinal Pigment Epithelial Detachment

Brazil
PD. Dr. med. Armin Wolf
University Hospital, Bonn

Unknown

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas (PEARL)

Central Retinal Vein Occlusion With Macular Edema
East Florida Eye Institute
Genentech, Inc.

Unknown

Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients

Age Related Macular Degeneration

United States
Bristol-Myers Squibb

Completed

Methotrexate-Inadequate Response Autoinjector Device Sub Study (MTX-IR)

Rheumatoid Arthritis
Allergan

Completed

A Study of Abicipar Pegol in Patients With Diabetic Macular Edema

Macular Edema

United States
Vitreous -Retina- Macula Consultants of New York
Genentech, Inc.

Withdrawn

Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration (SEIRA)

Age Related Macular Degeneration | CNV | AMD

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Radboud University Medical Center; University Medical Center Groningen; UMC Utrecht and other collaborators

Unknown

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) (BRVO)

Retinal Vein Occlusion

Netherlands
Prof. dr. R.O. Schlingemann
Radboud University Medical Center; University Medical Center Groningen; UMC Utrecht and other collaborators

Unknown

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) (BRDME)

Diabetic Macular Edema

Netherlands
Steven R. Sanislo
Genentech, Inc.; California Pacific Medical Center; Pacific Eye Associates

Completed

Lucentis in Advanced Macular Degeneration

Macular Degeneration

United States
Prince of Songkla University

Completed

Intraocular Pressure Change Following Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agent

Intraocular Pressure

Thailand
University of Zurich

Completed

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Macular Degeneration

Switzerland
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Foundation

Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events (RATE)

Coronary Artery Disease | Cerebrovascular Disorders | Age-related Macular Degeneration

Netherlands, Russian Federation
Retina Center, Minnesota
Genentech, Inc.

Completed

ERG/EOG Study in AMD Patients Treated With Ranibizumab (FVF4154s)

Age-Related Macular Degeneration

United States
Hanscom, Thomas, M.D.
Genentech, Inc.

Completed

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (RAVEN)

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

United States
Bristol-Myers Squibb

Completed

Phase IIIB Subcutaneous Missed Dose Study

Rheumatoid Arthritis

Argentina, Mexico, United States, South Africa, Canada
University of British Columbia

Completed

Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis (Humour)

Proliferative Diabetic Retinopathy (PDR)

Canada
Ursula Schmidt-Erfurth, M.D.

Completed

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Diabetic Retinopathy | Diabetic Macular Edema | Proliferative Diabetic Retinopathy

Austria
Eye Center of Northern Colorado, P.C.
Genentech, Inc.

Completed

High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia (HD-LIPT)

Retinal Diseases | Telangiectasis

United States
University of Luebeck

Completed

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD (LucERG)

Age-Related Macular Degeneration | Retinal Function

Germany
Institut de la Macula y la Retina
Centro Medico Teknon

Completed

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration (FUSION)

Exudative Age-related Macular Degeneration

Spain
Bristol-Myers Squibb

Completed

A Study of Abatacept in Patients With Active Ulcerative Colitis

Ulcerative Colitis

United States, Australia, India, Korea, Republic of, Poland, Canada, France, Brazil, Mexico, Puerto Rico, Belgium, Switzerland, Italy, Netherlands, Germany, Ireland, South Africa, United Kingdom, Czech Republic
OPKO Health, Inc.

Withdrawn

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) (CARBON)

Age Related Macular Degeneration
Retina Associates of Florida, P.A.

Completed

Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion (RaScaL)

Diabetic Macular Edema

United States
Rüdiger B. Müller
Bristol-Myers Squibb

Completed

Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday (A-BREAK)

Rheumatoid Arthritis

Switzerland
University Health Network, Toronto

Unknown

Geographic Atrophy and Intravitreal Ranibizumab Injections

Age-related Macular Degeneration | Geographic Atrophy

Canada
Quark Pharmaceuticals

Completed

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) (MATISSE)

Diabetic Retinopathy | Diabetic Macular Edema | Choroidal Neovascularization

United States, Israel, United Kingdom, Belgium, Germany, Poland, Czech Republic
Brian Burke, MPH

Unknown

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Retinal Vein Occlusion

United States
University of Utah
Genentech, Inc.

Terminated

Study Evaluating Genotypes Using Lucentis (SEAGUL)

Age-Related Maculopathy

United States
Yonsei University

Completed

Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion

Neovascular Age-related Macular Degeneration

Korea, Republic of
Universiti Sains Malaysia

Completed

Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study

Pterygium
Oslo University Hospital

Completed

LUCAS (Lucentis Compared to Avastin Study) (LUCAS)

Exudative Age-related Macular Degeneration

Norway

Search clinical trials for: Ranibizumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations